Search for company
Explore more than 1.3 million company profiles from emerging markets

Ipca Laboratories Ltd. (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Quote Chart
Quote Summary
Last Price 652.75
Volume 12,564
Turnover 8,304,490
Index    S&P CNX 500
Market Bombay Stock Exchange
Ticker 524494
Market Cap Market Cap 82,376,468
52 Week High 884.45
52 Week Low 616.40
P/E 17.21
EPS 37.92
Dividend Yield 1.2 (March 31, 2012)
Bookvalue 27,723,500
Enterprise Value 101,937,627
Quote updated on May 22, 2015
Note: data in INR Thousands.
Financials
Select Items to chart them. 2015 Q3
Net sales revenue
Total Operating Revenue
Operating profit (EBIT)
EBITDA
Net Profit(Loss)
Total Assets N/A
Total equity
Operating Profit Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to equity
Quick ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Individual
Source: World's Vest Base, EMIS Company Database.
Company Description

Ipca Laboratories Limited (IPCA), incorporated in 19 October, 1949 under the name of 'The Indian Pharmaceutical Combine Association Limited, operates as a Pharmaceutical company . IPCA manufactures, supplies and exports API's Atenolol (Antihypertensive), Chloroquine Phosphate (Antimalarial), Furosemide (Diuretic) and Pyrantel Salts (Anthelmintic). The company has its registered office located in Mumbai.

More
Main Products

Other Fiscal Benefits, Others, Other Services, Liquids (Oral), Injectibles, Formulation Capsules/Tablets, Basic Drugs/Intermediates,
More

More
Contact Information

Legal Address
48, Kandivli Industrial Estate,, Kandivli (West),
Mumbai; Maharashtra; Map
Postal Code: 400067
Tel: 66474444
Fax: 28686613
Email: investors@ipca.com
Website: http://www.ipca.com

Full name: Ipca Laboratories Ltd.

Previous name(s): THE INDIAN PHARMACEUTICAL COMBINE ASSOCIATION LIMITED (1949)

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
IN-CIN: L24239MH1949PLC007837
ISIN CODE : INE571A01012
Incorporation Date: 1949

Basic Information
Total Employees:
()
Outstanding Shares:
: ()
Registered Capital:
()
Financial Auditors:
()
Export-Import
2014: Imports INR 621,144.86 Thousands
Import connections ('000)
Total(9,807.83)
2014: Exports INR 2,187,826.64 Thousands
Export connections ('000)
Total(34,545.63)
Key Executives
Chairman & Managing Director
More
Ownership Details
Indian Promoters
45.89%
More
Affiliates and related companies
IPCA Pharma (Australia) Pty Ltd.
100%
More
Corporate Actions
EMIS Benchmark Score
EMIS DealWatch Deals
DealMonitor Deal Intents
EMIS DealWatch News
Financial Documents/Annual Reports
Competitors - India
INR | USD | EUR
Analysis/Research

Receive our Global EMIS Insider

The Global EMIS Insider is a our monthly source of Emerging Markets Information Service (EMIS) functionality enhancements and new content releases in each of our countries worldwide.
First Name: *
Country: *
Last Name: * Company: *
Email: * Position: *
Security Code: *   * Indicates required field.

USE OF YOUR INFORMATION:
EMIS is part of the Euromoney Institutional Investor PLC group of companies. Click here for more details on our group's activities.
We will use the information you provide here to process your order/registration/request including communicating with you about it. If you are registering for a trial, you will receive a follow up email and/or call asking you about your trial. As part of the trial, you may also receive email updates and other features as specified for that product. We may monitor your use of our website(s). As an international group, we may transfer your data on a global basis. Subject to your choices below, we may also use your data for marketing purposes. By submitting your details, you will be indicating your consent to the use of your data as identified here. Further information is set out in our privacy policy on this site.

Please tick if you don't want to receive details of products, services and special offers from our group companies by:

Phone    Fax    Email    Mail

Please tick if you don't want to receive details of relevant products, services and special offers from selected companies outside our group

I have read and agree to the Terms and Conditions.

I have read and agree to the Privacy Policy.